PAP
NUVB icon

Persistent Asset Partners’s Nuvation Bio NUVB Stock Holding History

Persistent Asset Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Buy
+2,607
New +$12.7K ﹤0.01% 647

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Persistent Asset Partners's NUVB Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Nuvation Bio (NUVB) in Q2 2026: 2,607 shares worth $14.8K. The stake represents ﹤0.01% of the portfolio and ranks #647 among its holdings.

244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Persistent Asset Partners held 2,607 shares of Nuvation Bio worth $14.8K as of Q2 2026.
  • Nuvation Bio was a new Persistent Asset Partners position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Persistent Asset Partners's portfolio in Q2 2026, its #647 holding.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.